Skip to main content
Fulltext search
Apply
Home
About
Overview
Directors & management
Services
Platforms
All platforms
LentiVector
®
platform
Adeno-Associated Virus (AAV) platform
Adenovirus expertise
TRiP System
TM
LentiStable
TM
Process development
Analytics
Commercially approved vectors
Automation and System Integration
Pipeline
ESG
Our ESG Mission and Responsible Business Strategy
Integrity and Ethics
People
Community
Environment
Innovation
Supply Chain
Investors
Investors homepage
Results, reports, presentations & webcasts
Regulatory news
Shareholder meetings, circulars & prospectuses
Financial calendar
Corporate governance
Board committees
Investor contacts
Analyst coverage and research reports
Share price information
Registrars
Warning to shareholders
News & events
Press releases
Events
Multimedia
Media contact details
Careers
Search
Contact
Contact form
Addresses
Fulltext search
Apply
Search results
(-)
Remove Webcasts and audio filter
Webcasts and audio
Analyst Presentation: Interim results for the six months ended 30 June 2017
https://oxb.com
/webcasts-and-audios/analyst-presentation-interim-results-six-months-ended-30-june-2017
Analyst conference call: Oxford BioMedica and Bioverativ Collaboration
https://oxb.com
/webcasts-and-audios/analyst-conference-call-oxford-biomedica-and-bioverativ-collaboration
Analyst conference call: Preliminary results for the year ended 31 December 2017
https://oxb.com
/webcasts-and-audios/analyst-conference-call-preliminary-results-year-ended-31-december-2017
Analyst conference call: Oxford BioMedica and Axovant Sciences enter into a $842.5 Million Exclusive Worldwide Licence Agreement for OXB-102 for the Treatment of Parkinson’s Disease
https://oxb.com
/webcasts-and-audios/analyst-conference-call-oxford-biomedica-and-axovant-sciences-enter-8425-million
Analyst Presentation: Interim results for the six months ended 30 June 2018
https://oxb.com
/webcasts-and-audios/analyst-presentation-interim-results-six-months-ended-30-june-2018
Webcast: Preliminary results for the year ended 31 December 2018
https://oxb.com
/webcasts-and-audios/webcast-preliminary-results-year-ended-31-december-2018
Analyst Presentation: Interim results for the six months ended 30 June 2019
https://oxb.com
/webcasts-and-audios/analyst-presentation-interim-results-six-months-ended-30-june-2019
Preliminary results for the year ended 31 December 2019
https://oxb.com
/webcasts-and-audios/preliminary-results-year-ended-31-december-2019
Oxford Biomedica Preliminary Results 2019
https://oxb.com
/webcasts-and-audios/oxford-biomedica-preliminary-results-2019
Annual General Meeting, 23 June 2020
https://oxb.com
/webcasts-and-audios/annual-general-meeting-23-june-2020
Pages
1
2
next ›
last »
Close
